Upcoming event

RCC19 delivers kidney cancer essentials in Prague


The first edition of the EAU Update on Renal Cell Cancer (RCC19) held from 7 to 8 June in picturesque Prague delivered the latest developments in RCC through comprehensive presentations, courses and lively discussions. 

The recently-concluded meeting showcased numerous discussions on relevant topics. The role of active surveillance was addressed by speakers Dr. Maria Carmen Mir Maresma and Prof. Alessandro Volpe.  Dr. Riccardo Campi and Dr. Maarten Albersen discussed how to use morphometric scores in the preoperative planning. Prof. Alex Mottrie and Prof. Andrea Minervini shared their expertise and how to optimize the surgical management of advanced RCC.

In the session “Update on localised Renal Cell Cancer (RCC)”, Dr. Campi and Prof. Minervini discussed the role for current classification system in assessing the complexity of partial nephrectomy, and the surgical techniques for tumour resection. Dr. Saeed Dabestani’s lecture was a comprehensive analysis about how to schedule a follow-up after curative treatment of localised renal cell carcinoma.

Dr. Laurence Albiges and Prof. Marc-Oliver Grimm presented interesting updates on locally advanced and metastatic RCC (mRCC), focusing on immunotherapy and biomarkers. The new combination therapies with pembrolizumab plus axinitinib, and avelumab plus axinitinib have been discussed in detail.

Afterwards, Dr. Grant Stewart addressed the role of cytoreductive nephrectomy in mRCC and Dr. Vsevolod Matveev presented data for optimising the surgical management of advanced RCC and vena cava thrombus.

Lifestyle, medication, nutrition and how these impact kidney cancer development, cancer-specific prognosis and Quality of Life were presented by Dr Sabine Brookman-May on RCC’s second day. Prof. Volpe did an update on the role of renal biopsy and Dr. Umberto Capitanio introduced the state-of-the-art and future perspectives of genomic characterisation of RCC. Prof. Morgan Rouprêt delivered his lecture on the outcomes of untreated RCC and the importance of frailty assessment.

Finally, in two highly-interactive round table discussions presented by Dr. Idir Ouzaid and Prof. Marc-Oliver Grimm, the role of surgery in complex cases and the multidisciplinary management of metastatic RCC were addressed as well.

Watch the selected webcasts from RCC19 selected by the UROONCO Kidney Cancer editorial board. 

For more information about the meeting, please visit the official website www.rcc.uroweb.org.